Depth of PSA Nadir and Subsequent PSA Progression-Free Survival in Patients (pts) with High-Risk Biochemically Relapsed Prostate Cancer: Results from the Phase 3 PRESTO study (AFT-19)
- Citation:
- JCO vol 41 (suppl 16) 5077
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Janssen
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Katharine Dooley David Hillman Han Xiao Joel Picus Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin James Mohler Daniel Anderson Glenn Heller Susan Halabi Alan Tan Scott E. Eggener Charles J. Ryan Michael J. Morris
- Networks:
- CA043, CA824, IL018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TN008, METROMIN, MN022, NH038
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: